Effect of external urinary collection device implementation on female surgical patients.


Journal

Infection, disease & health
ISSN: 2468-0869
Titre abrégé: Infect Dis Health
Pays: Netherlands
ID NLM: 101689703

Informations de publication

Date de publication:
11 2022
Historique:
received: 29 03 2022
revised: 31 05 2022
accepted: 31 05 2022
pubmed: 27 6 2022
medline: 9 11 2022
entrez: 26 6 2022
Statut: ppublish

Résumé

The Centers for Disease Control and Prevention reports that catheter-associated urinary tract infections (CAUTIs) are the most common hospital-acquired infection. Female external urinary collection devices (EUCDs) may be an alternative to indwelling urethral catheters (IUCs), thereby decreasing CAUTIs. However, no study has demonstrated that EUCDs can help reduce CAUTIs in female surgical patients. We sought to compare CAUTI rate and the median number of days an IUC was used before and after availability of this female EUCD for surgical patients. A retrospective analysis of adult female surgical patients admitted to a single academic institution who received an IUC and/or EUCD was performed. Patients who received an IUC three months before (PRE) EUCD availability (08/2017-10/2017) were compared to patients receiving an IUC and/or EUCD 12 months after (POST) (11/2017-11/2018). From 906 surgical patients receiving an IUC/EUCD, 127 received an EUCD in the POST cohort. Compared to the PRE, the POST had a higher rate of CAUTIs (infections per 1000 catheter days, 11.2 vs. 4.6, p = 0.017) and overall UTI rate (infections per 1000 catheter days, 5.4 vs. 4.8, p = 0.036), whereas IUC days were similar between cohorts (median, two vs. two days, p = 0.18). The POST cohort rate of EUCD UTI was 4.6 infections per 1000 device days. While EUCDs appear to be a promising alternative to IUCs for female surgical patients, this study found increased CAUTIs after introduction of an EUCD. Further research is needed to clarify if female EUCDs are effective in decreasing CAUTI prior to widespread adoption.

Sections du résumé

BACKGROUND
The Centers for Disease Control and Prevention reports that catheter-associated urinary tract infections (CAUTIs) are the most common hospital-acquired infection. Female external urinary collection devices (EUCDs) may be an alternative to indwelling urethral catheters (IUCs), thereby decreasing CAUTIs. However, no study has demonstrated that EUCDs can help reduce CAUTIs in female surgical patients. We sought to compare CAUTI rate and the median number of days an IUC was used before and after availability of this female EUCD for surgical patients.
METHODS
A retrospective analysis of adult female surgical patients admitted to a single academic institution who received an IUC and/or EUCD was performed. Patients who received an IUC three months before (PRE) EUCD availability (08/2017-10/2017) were compared to patients receiving an IUC and/or EUCD 12 months after (POST) (11/2017-11/2018).
RESULTS
From 906 surgical patients receiving an IUC/EUCD, 127 received an EUCD in the POST cohort. Compared to the PRE, the POST had a higher rate of CAUTIs (infections per 1000 catheter days, 11.2 vs. 4.6, p = 0.017) and overall UTI rate (infections per 1000 catheter days, 5.4 vs. 4.8, p = 0.036), whereas IUC days were similar between cohorts (median, two vs. two days, p = 0.18). The POST cohort rate of EUCD UTI was 4.6 infections per 1000 device days.
CONCLUSION
While EUCDs appear to be a promising alternative to IUCs for female surgical patients, this study found increased CAUTIs after introduction of an EUCD. Further research is needed to clarify if female EUCDs are effective in decreasing CAUTI prior to widespread adoption.

Identifiants

pubmed: 35753991
pii: S2468-0451(22)00027-X
doi: 10.1016/j.idh.2022.05.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-234

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Melinda Lem (M)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: lemmr@hs.uci.edu.

Nathan Jasperse (N)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA; University of California, Los Angeles (UCLA), Harbor UCLA Department of Emergency Medicine, 1000 W Carson Street, Torrance, CA, 90502, USA. Electronic address: njasperse@dhs.lacounty.gov.

Areg Grigorian (A)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA; University of Southern California (USC), Department of Surgery, 2051 Marengo Street, Los Angeles, CA, 90033, USA. Electronic address: areg.grigorian@med.usc.edu.

Catherine M Kuza (CM)

University of Southern California (USC), Department of Anesthesiology, 2051 Marengo Street, Los Angeles, CA, 90033, USA. Electronic address: catherine.kuza@med.usc.edu.

Jacob Sahag Deyell (JS)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: jdeyell@hs.uci.edu.

Janani Pankajam Prasad (JP)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: jpprasad@hs.uci.edu.

Charlene Yuan (C)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: charley3@hs.uci.edu.

Meril Tomy (M)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: mtomy@hs.uci.edu.

Jeffry Nahmias (J)

University of California, Irvine (UCI), Department of Surgery, 101 City Drive S, Orange, CA, 92868, USA. Electronic address: jnahmias@hs.uci.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH